Details for 2018213309

Up to date per 04.04.2026

Actions

Title / Product Name

CHINAZOLINDERIVATE ZUR BEHANDLUNG VON HIV

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2018213309

EP Publication Number

3521282

E-Number

1423673

Language

PCT Number

Publication Date

07.08.2019 A

25.08.2021 B1

Registration Date

25.08.2021

AT Publication Date

15.09.2021

Application Date

23.12.2015

Registration Number

Priorities

24.12.2014

201462096748 P

IPC

C07D 401/12 20060101AFI20200213BHEP

Maximum Duration of Protection

23.12.2035

Owner

Gilead Sciences, Inc.333 Lakeside Drive Foster City, CA 94404US

Institute of Organic Chemistry and Biochemistry AS CR, V.V.I.Flemingovo nam. 2 16610 Praha 6CZ

Representative

Haffner und Keschmann Patentanwälte GmbHSchottengasse 3a1010 WienAT

Inventor

JANSA, Petrc/o Gilead Sciences Inc 333 Lakeside Drive Foster City, CA 94404US

SIMON, Petrc/o IOCB of the AS CR V.V.I. Flemingovo Nam. 2. 166 10 Praha 6CZ

LANSDON, Ericc/o Gilead Sciences Inc 333 Lakeside Drive Foster City, CA 94404US

HU, Yunfeng Ericc/o Gilead Sciences Inc 333 Lakeside Drive Foster City, CA 94404US

BASZCZYNSKI, Ondrejc/o IOCB of the AS CR V.V.I. Flemingovo Nam. 2. 166 10 Praha 6CZ

DEJMEK, Milanc/o IOCB of the AS CR V.V.I. Flemingovo Nam. 2. 166 10 Praha 6CZ

MACKMAN, Richard, L.c/o Gilead Sciences Inc 333 Lakeside Drive Foster City, CA 94404US

Information about Fees